Evaluation of the in vivo anti-inflammatory and analgesic and in vitro anti-cancer activities of curcumin and its derivatives

Natural Product Communications

Volumn 8, Issue 3, 2013, Pages 359-362

  Jacob, James N ^a   Badyal, Dinesh K ^b   Bala, Suman ^b   Toloue, Masoud ^c  

^a Organomed Corporation   (United States)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c Bioo Scientific Corporation   (United States)

Author keywords

Anti cancer activity; Aspirin; Curcumin; Diacetylcurcumin; Diglutarylcurcumin; Paw edema; Tail flick

Indexed keywords

ACETYLSALICYLIC ACID; CARRAGEENAN; CURCUMIN; CURCUMIN DIACETATE; CURCUMIN DIGLUTARATE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; LATENT PERIOD; LIPOPHILICITY; LOW DRUG DOSE; MAXIMUM PERCENTAGE EFFECT; MEDICAL PARAMETERS; MOUSE; NONHUMAN; PANCREAS CANCER; PAW EDEMA; PROSTATE CANCER; RAT; TAIL FLICK TEST;

EID: 84875782832     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1300800321     Document Type: Article

References (21)

1. (a) Strimpakos AS, Sharma R. (2008) Curcumin: Preventive and therapeutic properties in laboratory studies and clinical trials. Antioxidants & Redox Signaling, 10, 1-35;
2. (b) Esatbeyoglu T, Huebbe P, Ernst IM, Chin D, Wagner AE, Rimbach G. (2012) Curcumin-from molecule to biological function. Angewandte Chemie International Edition English, 51, 5308-5332;
3. (c) Zandi K, Ramedani E, Mohammadi K, Tajbakhsh S, Deilami I, Rastian Z, Eouladvand M, Yousefi F, Farshadpour F. (2010) Evaluation of antiviral activities of curcumin derivatives against HSV-1 in vero cell line. Natural Product Communications, 5, 1935-1938;
4. (d) Chen CY, Yang WL, Kuo SY. (2011) Cytotoxic activity and cell cycle analysis of hexahydrocurcumin on SW 480 human colorectal cancer cells. Natural Product Communications, 6, 1671-1672;
5. (e) Kim MK, Park JC, Chong Y. (2012) Aromatic hydroxyl group plays a critical role in antibacterial activity of the curcumin analogues. Natural Product Communications, 7, 57-58.
6. Basile V, Ferrari E, Lazzari S, Belluti S, Pignedoli F, Imbriano C. (2009) Curcumin derivatives: molecular basis of their anti-cancer activity. Biochemical Pharmacology, 78, 1305-1315.
7. Kunwar A, Barik A, Pandey R, Priyadarsini KI. (2006) Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study. Biochimica et Biophysica Acta, 1760, 1513-1520.
8. Kumar V, Lewis SA, Mutalik S, Shenoy DB, Venkatesh, Udupa N. (2002) Biodegradable microspheres of curcumin for treatment of inflammation. Indian Journal of Physiology and Pharmacology, 46, 209-217.
9. Tiyaboonchai W, Tungpradit W, Plianbangchang P. (2007) Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. International Journal of Pharmaceutics, 337, 299-306.
10. Gupta NK, Dixit VK. (2011) Bioavailability enhancement of curcumin by complexation with phosphatidyl choline. Journal of Pharmaceutical Sciences, 100, 1987-1995.
11. Alam S, Panda JJ, Chauhan VS. (2012) Novel dipeptide nanoparticles for effective curcumin delivery. International Journal of Nanomedicine, 7, 4207-4222.
12. Mukhopadhyay A, Basu N, Ghatak N, Gujral PK. (1982) Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions, 12, 508-515.
13. Bamgbose SOA, Noamesi BK. (1981) Studies on cryptolepine inhibition of carrageenan-induced oedema. Planta Medica, 42, 392-396.
14. Awe SO, Olajide OA, Adeboye JO, Makinde JM. (1998) Some pharmacological studies on morinda lucida. Indian Journal of Pharmacology, 30, 38-42.
15. D'Armour FE, Smith DL. (1941) A method for determining loss of pain sensation. Journal of Pharmacology and Experimental Therapeutics, 72, 74-79.
16. Winter CA, Risley EA, Nuss GW. (1963) Carrageenan-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proceedings of the Society of Experimental Biology and Medicine, 111, 544-547.
17. Vinegar R, Schreiber W, Hugo R. (1969) Biphasic development of carrageenan oedema in rats. Journal of Pharmacology and Experimental Therapeutics, 166, 96-103.
18. Jana U, Chattopadhyay RN, Shaw BP. (1999) Preliminary studies on anti-inflammatory activity of Zingiber officinale Rosc., Vitex negundo Linn, and Tinospora cordifolia (Willid) Miers in albino rats. Indian Journal of Pharmacology, 31, 232-233.
19. Singh RK, Pandey BL. (1996) Antiinflammatory activity of seed extracts of Pongamia pinnata in rat. Indian Journal of Physiology and Pharmacology, 40, 355-358.
20. Choudhuri T, Pal S, Das T, Sa G. (2005) Curcumin selectively induces apoptosis in deregulated cyclin d1-expressed cells at g2 phase of cell cycle in a p53-dependent manner. Journal of Biological Chemistry, 280, 20059-20068.
21. Syng-ai C, Kumari AL, Khar A. (2004) Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2. Molecular Cancer Therapeutics, 3, 1101-1108.